Welcome > Support > Âü°íÀÚ·á  
 
 
E
 
±Ûº¸±â
¼º¸í ÆÄ³ªÁø     (Date : 2010-12-09 09:18:42)
Á¦¸ñ [³í¹®] [ÆÄ³ªÁø ³í¹®¹ßÇ¥] PNA-mediated Real-Time PCR Clamping for Detection of EGFR Mutations
³»¿ë

Bull. Korean Chem. Soc. 2010, Vol. 31, No. 12 3525
DOI 10.5012/bkcs.2010.31.12.3525


PNA-mediated Real-Time PCR Clamping for Detection of EGFR Mutations

Jae-jin Choi, Minhey Cho, Miae Oh, Hyunsun Kim, Min-seock Kil, and Heekyung Park

Panagene, Inc. , Daejeon, Korea.

Abstract

Tyrosine kinase inhibitors (TKIs) are currently used in the treatment of patients with advanced lung cancer. Recent studies on non-small cell lung cancer have shown that some patients carry somatic mutations in the epidermal growth factor receptor (EGFR) gene. Such mutations correlate with the effectiveness of certain TKIs. To detect a small amount of mutant EGFR among an abundance of wild-type EGFR, we have developed a highly sensitive and simple method using PNAmediated real-time PCR clamping. The PNA-mediated real-time PCR clamping enables detection of EGFR mutants down to approximately 1% mutant -to- wild type. The total assay time was short as it required only 2.0 hr. Thus, PNAmediated real-time PCR clamping can easily be applied to clinical samples for identification of DNA carrying EGFR mutations and also appear to be the best assay to detect somatic mutations.

* ÀÚ¼¼ÇÑ ³»¿ëÀº ÷ºÎÆÄÀÏ ÂüÁ¶ ¹Ù¶ø´Ï´Ù.


 

 ¹øÈ£   Á¦¸ñ ÀÛ¼ºÀÚ ÆÄÀÏ Á¶È¸
   49           [³í¹®] [2016]Comparison of EGFR .. ÆÄ³ªÁø 32719
   48           [³í¹®] [2015]IDH Mutation Analys.. ÆÄ³ªÁø 65535
   47           [³í¹®] [2015]Low frequency of KR.. ÆÄ³ªÁø 44069
   46           [³í¹®] [2015]Simultaneous genoty.. ÆÄ³ªÁø 6683
   45           [³í¹®] [2014]Simultaneous diagno.. ÆÄ³ªÁø 26810
   44           [³í¹®] [2014]KRAS Mutation Detec.. ÆÄ³ªÁø 13789
   43           [³í¹®] [2013]Detection of EGFR m.. ÆÄ³ªÁø 1534
   42           [³í¹®] [2013]Detection and compa.. ÆÄ³ªÁø 6187
   41           [³í¹®] [2013]Detection of BRAF V.. ÆÄ³ªÁø 6580
   40           [³í¹®] [2013]Comparison of Direc.. ÆÄ³ªÁø 35007
   39           [³í¹®] [Microarray]Peptide nucle.. ÆÄ³ªÁø 20228
   38           [³í¹®] [Clamp]Rapid and Sensitiv.. ÆÄ³ªÁø 65535
   37           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] EGFR µ¹¿¬º¯.. ÆÄ³ªÁø 3852
   36           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] Development .. ÆÄ³ªÁø 49752
   35           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] JHDM3A modul.. ÆÄ³ªÁø 1650
   34           [³í¹®] [PNA Chip vs DNA Chip ÀÓ»ó.. ÆÄ³ªÁø 28813
¢º           [³í¹®] [ÆÄ³ªÁø ³í¹®¹ßÇ¥] PNA-mediated Re.. ÆÄ³ªÁø 17652
   32           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡.. ÆÄ³ªÁø 33442
   31           [³í¹®] [ÆÄ³ªÁø ³í¹® ¹ßÇ¥] PNA-Based Anti.. ÆÄ³ªÁø 4162
   30           [³í¹®] [ÆÄ³ªÁø ³í¹®¹ßÇ¥]Peptide nucleic .. ÆÄ³ªÁø 4398
 

< 1 2 3 >